Delving into the Latest Updates on Shanghai Boyue Biotechnology Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	2
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

AXL x c-Met	1

主要目的：以上海博悦生物科技有限公司的盐酸乙哌立松片（规格：50mg；生产厂家：华益泰康药业股份有限公司）为受试制剂，以卫材（中国）药业有限公司的盐酸乙哌立松片（商品名：妙纳®，规格：50mg；生产厂家：卫材（中国）药业有限公司）为参比制剂，按生物等效性试验的有关规定，考察两制剂在健康人体内的生物等效性。次要目的：观察受试制剂和参比制剂在健康受试者中的安全性。

[Translation]

Main purpose: Using Eperisone Hydrochloride Tablets (Specification: 50 mg; Manufacturer: Huayi Taikang Pharmaceutical Co., Ltd.) of Shanghai Boyue Biotechnology Co., Ltd. as the test preparation and Eperisone Hydrochloride Tablets (Trade name: Myona®, Specification: 50 mg; Manufacturer: Eisai (China) Pharmaceutical Co., Ltd.) of Eisai (China) Pharmaceutical Co., Ltd. as the reference preparation, according to the relevant provisions of the bioequivalence test, the bioequivalence of the two preparations in healthy humans was investigated. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects.

Start Date15 Nov 2024

Sponsor / Collaborator

Shanghai Boyue Biotechnology Co., Ltd.

CTR20243446

/ CompletedNot Applicable

盐酸乙哌立松片在健康受试者中的单剂量、随机、开放、完全重复交叉、两制剂、四周期餐后人体生物等效性试验

[Translation] A single-dose, randomized, open-label, completely repeated crossover, two-dose, four-period fed human bioequivalence study of eperisone hydrochloride tablets in healthy subjects

主要目的：以上海博悦生物科技有限公司的盐酸乙哌立松片（规格：50mg；生产厂家：华益泰康药业股份有限公司）为受试制剂，以卫材（中国）药业有限公司的盐酸乙哌立松片（商品名：妙纳®，规格：50mg；生产厂家：卫材（中国）药业有限公司）为参比制剂，按生物等效性试验的有关规定，考察两制剂在健康人体内的生物等效性。次要目的：观察受试制剂和参比制剂在健康受试者中的安全性。

[Translation]

Main purpose: Using Eperisone Hydrochloride Tablets (Specification: 50 mg; Manufacturer: Huayi Taikang Pharmaceutical Co., Ltd.) of Shanghai Boyue Biotechnology Co., Ltd. as the test preparation and Eperisone Hydrochloride Tablets (Trade name: Myona®, Specification: 50 mg; Manufacturer: Eisai (China) Pharmaceutical Co., Ltd.) of Eisai (China) Pharmaceutical Co., Ltd. as the reference preparation, according to the relevant provisions of the bioequivalence test, the bioequivalence of the two preparations in healthy humans was investigated. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects.

Start Date17 Sep 2024

Sponsor / Collaborator

Shanghai Boyue Biotechnology Co., Ltd.

100 Clinical Results associated with Shanghai Boyue Biotechnology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Boyue Biotechnology Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Boyue Biotechnology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Boyue Biotechnology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

2

Login to view more data